IMMUNOCONJUGUÉS ANTI-FOLR1 ET COMBINAISONS D'ANTICORPS ANTI-PD-1

• 收藏
• 分享

专利权人:

ImmunoGen, Inc.;Merck Sharp & Dohme Corp.

发明人:

申请号：

EP18802195.0

公开号：

EP3625262A1

申请日:

2018.05.15

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Therapeutic combinations of immunoconjugates that bind to FOLR1 (e.g., IMGN853) with anti-PD-1 antibodies or antigen-binding fragments thereof (e.g., pembrolizumab) are provided. Methods of administering the combinations to treat cancers, e.g., ovarian, peritoneal, or fallopian tube cancers, with greater clinical efficacy and/or decreased toxicity are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/